« Previous
Next »
Gastroenterology
Volume 135, Issue 2
, Pages
459-467
, August 2008
Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b
To access this article, please choose from the options below
Organized and sponsored by the Foundation for Liver Research (SLO) (Rotterdam, The Netherlands) and supported by Schering-Plough International (Kenilworth, NJ).
E.H.C.J.B. has received speaker's honoraria from Novartis and Roche. S.V.F. has served as a consultant for Hoffman-La Roche and Schering-Plough and has received research support from Schering-Plough. H.L.A.J. has served as a consultant for Bristol-Myers Squibb, Gilead, Novartis, and Roche and has received research support from Bristol-Myers Squibb, Novartis, Roche, and Schering-Plough. The following authors have nothing to disclose: H.J.F., Y.C., K.S., J.T., F.T., T.M.K.S., T.M., U.S.A., M.S., W.T., A.J.V., and B.E.H. Potential investigator conflicts of interest have not been disclosed to study participants.
Members of the HBV99-01 LTFU study group include the following: Belgium: F. Nevens, E. de Wit (University Hospital Gasthuisberg, Leuven); P. P. Michielsen, R. Braspenning (University Hospital, Antwerp); H. van Vlierberghe, A. de Geyter (University Hospital, Gent). Canada: E. J. Heathcote, D. Kaznowski (Toronto Western Hospital University Health Network, Toronto); S. Bojarski (Liver Disease Unit, Mount Sinai Hospital, Toronto). Denmark: L. R. Mathiesen, G. Kronborg, L. Rosenørn (Copenhagen University Hospital, Hvidovre). Germany: G. Gerken, S. Bein (University Hospital, Essen). Greece: G. Kitis (George Papanikolaou General Regional Hospital, Thessaloniki). Italy: G. B. Gaeta (Ospedale Gesù e Maria, Napoli); F. D'Antona, G. Montalto (Università di Palermo, Palermo). Malaysia: S. Sharmila (Hospital Selayang, Institute for Medical Research, Kuala Lumpur). The Netherlands: E. Verhey, G. Ramdjan, L. A. van Santen, A. Heijens, M. Ouwendijk, J. Francke, S. Diepstraten-Pas (Erasmus MC University Medical Center, Rotterdam); C. M. J. van Nieuwkerk, C. van Doorn (VU University Medical Center, Amsterdam); J. Drenth (University Medical Centre Radboud, Nijmegen); J. W. den Ouden-Muller (St Franciscus Hospital, Rotterdam); R. A. de Vries, P. van Embden (Rijnstate Hospital, Arnhem). Poland: R. Flisiak (Medical University of Białystok, Białystok). Singapore: R. Guan (Mount Elizabeth Medical Center, Singapore). Spain: M. Buti (Hospital General Universitari Pall d'Hebron, Barcelona); M. Rodriguez (Hospital Central de Asturias, Oviedo). Turkey: H. Simsek (Hacettepe University Faculty of Medicine, Ankara).
PII: S0016-5085(08)00850-0
doi: 10.1053/j.gastro.2008.05.031
© 2008 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 135, Issue 2
, Pages
459-467
, August 2008

